Influenza Inactive Virus Vaccine With the Fusion Peptide (rTα1- BP5) Enhances Protection Against Influenza Through Humoral and Cell-Mediated Immunity
doi 10.5772/64403
Full Text
Open PDFAbstract
Available in full text
Date
October 26, 2016
Authors
Publisher
InTech